Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib

Alan H. Bryce, Mitesh J. Borad, Jan B. Egan, Rachel M. Condjella, Winnie S. Liang, Rafael Fonseca, Ann E. McCullough, Katherine S. Hunt, Nicole R. Ritacca, Michael T. Barrett, Maitray D. Patel, Scott W. Young, Alvin C. Silva, Thai H. Ho, Thorvardur R. Halfdanarson, Melissa L. Stanton, John Cheville, Scott Swanson, Daniel E. Schneider, Robert R. McWilliamsAngela Baker, Jessica Aldrich, Ahmet Kurdoglu, Tyler Izatt, Alexis Christoforides, Irene Cherni, Sara Nasser, Rebecca Reiman, Lori Cuyugan, Jacquelyn McDonald, Jonathan Adkins, Stephen D. Mastrian, Daniel D. Von Hoff, David W. Craig, A. Keith Stewart, John D. Carpten

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)e727-e734
JournalClinical Genitourinary Cancer
Volume15
Issue number4
DOIs
StatePublished - Aug 2017

Keywords

  • EGFR
  • Exome
  • Genome
  • Transcriptome
  • Urethral adenocarcinoma

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this